These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3704532)

  • 21. Iopamidol vs. metrizamide myelography: clinical comparison of side effects.
    Trevisan C; Malaguti C; Manfredini M; Tampieri D
    AJNR Am J Neuroradiol; 1983; 4(3):306-8. PubMed ID: 6410728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of iopamidol with three other contrast media in orbital venography/cavernous sinography.
    Macpherson P
    Br J Radiol; 1982 Jul; 55(655):539-40. PubMed ID: 7150905
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of radiographic quality and adverse reactions in myelography with iopamidol and metrizamide.
    Bannon KR; Braun IF; Pinto RS; Manuell M; Sudilovsky A; Kricheff II
    AJNR Am J Neuroradiol; 1983; 4(3):312-3. PubMed ID: 6410730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Excretory urography--current indications of the status of a conventional diagnostic method. Status of nonionic and ionic contrast media].
    Porst H; Mayer R
    Fortschr Med; 1985 Aug; 103(30):755-8. PubMed ID: 4043912
    [No Abstract]   [Full Text] [Related]  

  • 25. [Myelography and headache].
    Hammer B
    Wien Med Wochenschr; 1985 Jun; 135(11):259-63. PubMed ID: 3895752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of the acute cardiovascular side effects of iopamidol, metrizamide and amidotrizoate after intracoronary and left ventricular injections].
    Schräder R; Wolpers HG; Hoeft A; Korb H; Hellige G
    Radiologe; 1984 May; 24(5):240-6. PubMed ID: 6463236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intrathecal roentgen contrasting--experiences with iopamidol].
    Stellamor V; Stellamor K; Perneczky G
    Rontgenpraxis; 1984 Jun; 37(6):213-9. PubMed ID: 6548320
    [No Abstract]   [Full Text] [Related]  

  • 28. Iopamidol for myelography. A clinical trial with a new non-ionic contrast medium.
    Peeters F; van Dongen K; Hekster R; Hoogland P; Thijssen H; Tjian T; Wilmink J; Althuisius H
    Diagn Imaging; 1983; 52(6):313-5. PubMed ID: 6357678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Myelography with water-soluble contrast media in the diagnosis of space-occupying spinal lesions].
    Schmidt RC
    Rontgenpraxis; 1982 May; 35(5):166-73. PubMed ID: 7089723
    [No Abstract]   [Full Text] [Related]  

  • 30. [Transient hypothyroidism in infants following administration roentgen contrast media].
    Röhner G; Rautenburg HW; Höpfner B
    Rontgenpraxis; 1983 Sep; 36(9):301-4. PubMed ID: 6635827
    [No Abstract]   [Full Text] [Related]  

  • 31. The prophylactic use of phenytoin during iopamidol contrast studies of the subarachnoid space.
    de Vane PJ; Macpherson P; Teasdale E; Volo G; Casey M; Kelly JC; Whiting B
    Eur J Clin Pharmacol; 1986; 29(6):747-9. PubMed ID: 3709621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Side effects and contrast medium resorption of iopamidol and iocarmate in lumbar myelography].
    Stoeter P; Bergleiter R; Schneider I; Kubina FG
    Computertomographie; 1982 Dec; 2(4):179-83. PubMed ID: 6821243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of the side effects of urographic contrast media (iothalamate, diatrizoate, iodamide, iopamidol) within the scope of a CT study].
    Stellamor K; Hruby W; Assinger S; Luckner H
    Radiologe; 1984 Oct; 24(10):488-90. PubMed ID: 6505221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience with iopamidol for myelography.
    Bockenheimer SA; Hillesheimer W
    AJNR Am J Neuroradiol; 1983; 4(3):314-6. PubMed ID: 6410731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse reaction to iopamidol.
    Robinson C; Fon G
    Med J Aust; 1986 May; 144(10):553. PubMed ID: 3713572
    [No Abstract]   [Full Text] [Related]  

  • 36. [Enzyme determination in the urine for the evaluation of kidney tolerance of the water-soluble roentgen contrast medium iopamidol].
    Hartmann HG; Jutzler GA; Bambauer R; Keller HE; Maruhn D
    Radiologe; 1984 Sep; 24(9):442-5. PubMed ID: 6494455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ["Contrast medium arachnitis' following lumbosacral myelography with water-soluble contrast media].
    Claass A; Piepgras U; Wussow W
    Rontgenpraxis; 1982 May; 35(5):174-85. PubMed ID: 7046088
    [No Abstract]   [Full Text] [Related]  

  • 38. [Peripheral arteriography at an advanced age using a new contrast agent].
    Siemers M
    Rontgenblatter; 1984 Apr; 37(4):140-2. PubMed ID: 6729363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Coagulation disorder following angiography with a nonionic tri-iodized contrast medium? Effect due to contrast medium or to heparin?].
    Maurer HJ
    Rofo; 1985 Dec; 143(6):718-9. PubMed ID: 3001869
    [No Abstract]   [Full Text] [Related]  

  • 40. Iopamidol for myelography--practical implications.
    de Villiers PD; Snyman PJ; van Rensburg MN; Lamprecht DS; Greeff GP
    S Afr Med J; 1984 Nov; 66(18):697-8. PubMed ID: 6495113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.